Cargando…

Thromboprophylaxis After Hospitalization for Joint Replacement Surgery

Venous thromboembolism (VTE) is a leading cause of mortality during the perioperative period, with individuals who have undergone hip and knee arthroplasty at the highest risk for VTE. The American College of Chest Physicians recommends 35 days of postoperative thromboprophylaxis and the use of inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliano, Karen K., Pozzar, Rachel, Hatch, Courtney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432178/
https://www.ncbi.nlm.nih.gov/pubmed/31082932
http://dx.doi.org/10.1097/JHQ.0000000000000204
_version_ 1783571740158328832
author Giuliano, Karen K.
Pozzar, Rachel
Hatch, Courtney
author_facet Giuliano, Karen K.
Pozzar, Rachel
Hatch, Courtney
author_sort Giuliano, Karen K.
collection PubMed
description Venous thromboembolism (VTE) is a leading cause of mortality during the perioperative period, with individuals who have undergone hip and knee arthroplasty at the highest risk for VTE. The American College of Chest Physicians recommends 35 days of postoperative thromboprophylaxis and the use of intermittent pneumatic compression (IPC) therapy for mechanical compression after major orthopedic surgery. However, little research has described adherence to these recommendations during recovery at home. The purpose of this cross-sectional descriptive study was to describe thromboprophylaxis prescription, use, and education among patients discharged home after major orthopedic surgery. We surveyed patients within 2 years of major orthopedic surgery. A total of 388 subjects completed the survey. More than three-quarters of respondents reported a thromboprophylaxis duration <35 days. Most (93.8%) respondents were prescribed a pharmacologic agent, while 55.9% were prescribed mechanical compression therapy. Of the respondents who were prescribed mechanical compression therapy, 13.4% were prescribed IPC. Adherence to mechanical compression therapy was moderate, with 63% of respondents wearing mechanical compression therapy ≥75% of the time. The results of this study suggest a need for increased duration of thromboprophylaxis and increased use of IPC in the outpatient setting. Additional research describing prescribers' perceptions of thromboprophylaxis is also needed.
format Online
Article
Text
id pubmed-7432178
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74321782020-09-04 Thromboprophylaxis After Hospitalization for Joint Replacement Surgery Giuliano, Karen K. Pozzar, Rachel Hatch, Courtney J Healthc Qual Original Article Venous thromboembolism (VTE) is a leading cause of mortality during the perioperative period, with individuals who have undergone hip and knee arthroplasty at the highest risk for VTE. The American College of Chest Physicians recommends 35 days of postoperative thromboprophylaxis and the use of intermittent pneumatic compression (IPC) therapy for mechanical compression after major orthopedic surgery. However, little research has described adherence to these recommendations during recovery at home. The purpose of this cross-sectional descriptive study was to describe thromboprophylaxis prescription, use, and education among patients discharged home after major orthopedic surgery. We surveyed patients within 2 years of major orthopedic surgery. A total of 388 subjects completed the survey. More than three-quarters of respondents reported a thromboprophylaxis duration <35 days. Most (93.8%) respondents were prescribed a pharmacologic agent, while 55.9% were prescribed mechanical compression therapy. Of the respondents who were prescribed mechanical compression therapy, 13.4% were prescribed IPC. Adherence to mechanical compression therapy was moderate, with 63% of respondents wearing mechanical compression therapy ≥75% of the time. The results of this study suggest a need for increased duration of thromboprophylaxis and increased use of IPC in the outpatient setting. Additional research describing prescribers' perceptions of thromboprophylaxis is also needed. Lippincott Williams & Wilkins 2019 2019-11-08 /pmc/articles/PMC7432178/ /pubmed/31082932 http://dx.doi.org/10.1097/JHQ.0000000000000204 Text en © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the National Association for Healthcare Quality. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Article
Giuliano, Karen K.
Pozzar, Rachel
Hatch, Courtney
Thromboprophylaxis After Hospitalization for Joint Replacement Surgery
title Thromboprophylaxis After Hospitalization for Joint Replacement Surgery
title_full Thromboprophylaxis After Hospitalization for Joint Replacement Surgery
title_fullStr Thromboprophylaxis After Hospitalization for Joint Replacement Surgery
title_full_unstemmed Thromboprophylaxis After Hospitalization for Joint Replacement Surgery
title_short Thromboprophylaxis After Hospitalization for Joint Replacement Surgery
title_sort thromboprophylaxis after hospitalization for joint replacement surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432178/
https://www.ncbi.nlm.nih.gov/pubmed/31082932
http://dx.doi.org/10.1097/JHQ.0000000000000204
work_keys_str_mv AT giulianokarenk thromboprophylaxisafterhospitalizationforjointreplacementsurgery
AT pozzarrachel thromboprophylaxisafterhospitalizationforjointreplacementsurgery
AT hatchcourtney thromboprophylaxisafterhospitalizationforjointreplacementsurgery